SCHEMBL1892074

SCHEMBL1892074

CCOCc1nc2cnc3ccccc3c2n1CC1(O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 10/20 0.44
TLR8 Q9NR97 8/20 0.44
NUDT1 P36639 1/20 0.44
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
PDE10A Q9Y233 1/20 0.33
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 2/20 0.32
MAPT P10636 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
CRHBP P24387 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1140821 0.96 TLR7 (0.42) TLR7TLR8NUDT1MEN1KMT2A
SCHEMBL1141057 0.96 TLR7 (0.42) TLR7TLR8NUDT1MEN1KMT2A
SCHEMBL1141121 0.95 TLR7 (0.42) TLR7TLR8NUDT1MEN1KMT2A
SCHEMBL1141014 0.93 TLR7 (0.42) TLR7TLR8NUDT1MEN1KMT2A
SCHEMBL1141187 0.93 TLR7 (0.41) TLR7TLR8NUDT1MEN1KMT2A
SCHEMBL1141096 0.92 TLR7 (0.39) TLR7TLR8NUDT1MEN1KMT2A
SCHEMBL1140906 0.90 HIF1A (0.39) TLR7TLR8NUDT1MEN1KMT2A
SCHEMBL5148465 0.90 TLR7 (0.40) TLR7TLR8NUDT1MEN1KMT2A
SCHEMBL1140988 0.89 TLR8 (0.44) TLR7TLR8NUDT1MEN1KMT2A
SCHEMBL1140873 0.89 SMN1; SMN2 (0.40) TLR7TLR8NUDT1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939526-B2 Sulfone substituted imidazo ring ethers 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-05-10 US disclosed
US-20070155767-A1 Sulfone substituted imidazo ring ethers 3M INNOVATIVE PROPERTIES COMPANY 2007-07-05 US disclosed
EP-1694674-A2 SULFONE SUBSTITUTED IMIDAZO RING ETHERS 3M Innovative Properties Company (US) 2006-08-30 EP disclosed
WO-2005076783-A2 SULFONE SUBSTITUTED IMIDAZO RING ETHERS 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155767-A1 Sulfone substituted imidazo ring ethers IL2, IL4, IFNG TLR7 82/4885TLR8 145/4885NUDT1 2054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.